Advair Relaunch And Nasal Naloxone Nod Raise Hikma’s Expectations

Also Strikes Branded Injectables Deal With Melinta For MENA Region

 
• By David Wallace
  
Dial Gauge High
Hikma expects its generics business to hit the top end of its 2021 forecast • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business